New strategies for developing drugs to treat multiple sclerosis and Alzheimer's are being recommended by researchers at the University of Houston.
A study has discovered that two estrogen receptors could target the problems caused by Alzheimer's, multiple sclerosis, cancer and cardiovascular diseases.
Dr Jan-Ake Gustafsson, University of Houston professor and Centre for Nuclear Receptors and Cell Signaling director, stated: "We have known for some time that female sex hormones-estrogens-influence a number of functions in the body.
"Only recently we and others found that one of the estrogen receptors - ERβ - is a potential target for the treatment of Alzheimer's and other chronic diseases."
Researchers have previously claimed that estrogen patches may improve the symptoms of Alzheimer's disease in women.
In a study of 20 women who were given either an estrogen patch or a placebo, women who had estrogen patches improved their performance by 20 per cent in a range of cognitive tests.
Find out more about Alzheimer's disease care at Barchester home.